Company GlaxoSmithKline Consumer Nigeria Plc

GLAXOSMITH

NGGLAXOSMTH8

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

Inactive Instrument

GlaxoSmithkline Consumer Nigeria specializes in manufacturing and marketing pharmaceutical, hygiene and health care products. Net sales break down by activity as follows:

- sale of consumer healthcare products (70.7%): nutritional supplements, OTC drugs and oral care products;

- sale of drugs (29.3%): antibacterial drugs, prescription drugs and vaccines.

Number of employees: 51

Managers	Title	Age	Since
Kunle Oyelana CEO	Chief Executive Officer	-	19-05-31
Bosco Kirugi DFI	Director of Finance/CFO	-	19-05-31
Olanike Olakanle CMP	Compliance Officer	-	-
Oluchi Ononiwu CMP	Compliance Officer	-	19-06-30
Omolaja Odunuga CTO	Chief Tech/Sci/R&D Officer	-	11-07-31
Victor Joachim CTO	Chief Tech/Sci/R&D Officer	-	-
Omongiade Ehighebolo IRO	Public Communications Contact	-	17-01-31
Alexandra Olukunle HRO	Human Resources Officer	-	11-12-31
Sylvester Ejiofor PRN	Corporate Officer/Principal	-	-
Nelson Sanni PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Oludewa Edodo-Thorpe BRD	Director/Board Member	-	19-12-04
Edmund Onuzo CHM	Chairman	76	06-05-31
Samuel Kuye BRD	Director/Board Member	71	14-06-11
Kunle Oyelana CEO	Chief Executive Officer	-	19-05-31
Bosco Kirugi DFI	Director of Finance/CFO	-	19-05-31
Amina Salihu BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,195,876,000	640,349,877 ( 53.55 %)	0	53.55 %

Name	Equities	%	Valuation
St. Galler Kantonalbank AG (Private Banking) 0.0543 %	649,958	0.0543 %	7 845 ₦
Renaissance Asset Managers (UK) Ltd. 0.0512 %	612,500	0.0512 %	7 393 ₦
Ashmore Equities Investment Management (US) LLC 0.0206 %	246,499	0.0206 %	2 975 ₦

GlaxoSmithKline Consumer Nigeria Plc

GSK House 1, Industrial Avenue

100252, Lagos

+234 1 2711000

http://www.gsk.com/ng

address GlaxoSmithKline Consumer Nigeria Plc(GLAXOSMITH)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+27.40%	672B
NOVO NORDISK A/S	+27.00%	570B
JOHNSON & JOHNSON	-6.04%	360B
MERCK & CO., INC.	+15.38%	321B
ABBVIE INC.	+8.55%	300B
ASTRAZENECA PLC	+7.21%	217B
ROCHE HOLDING AG	-9.37%	204B
NOVARTIS AG	+5.55%	199B
PFIZER, INC.	-9.34%	149B